These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ofloxacin concentrations in tissues involved in respiratory tract infections. Perea EJ J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591 [TBL] [Abstract][Full Text] [Related]
8. The use of quinolones in respiratory tract infections. Maesen FP; Davies BI; Geraedts WH; Baur C Drugs; 1987; 34 Suppl 1():74-9. PubMed ID: 3325259 [TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients. Pedersen SS; Jensen T; Hvidberg EF J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419 [TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of ofloxacin tablets in comparison to oral solution. Malerczyk V; Verho M; Korn A; Rangoonwala R Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296 [TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections. Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948 [TBL] [Abstract][Full Text] [Related]
13. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections. Nakamori Y; Miyashita Y; Nakatani I; Nakata K Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384 [No Abstract] [Full Text] [Related]
14. The effect of food on the pharmacokinetics of ofloxacin. Verho M; Malerczyk V; Dagrosa E; Korn A Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737 [TBL] [Abstract][Full Text] [Related]
15. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. Davies BI; Maesen FP; Teengs JP J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ofloxacin and theophylline alone and in combination. Fourtillan JB; Granier J; Saint-Salvi B; Salmon J; Surjus A; Tremblay D; Vincent Du Laurier M; Beck S Infection; 1986; 14 Suppl 1():S67-9. PubMed ID: 3456985 [TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis. Lam WK; Chau PY; So SY; Leung YK; Chan JC; Sham MK Infection; 1986; 14 Suppl 4():S290-2. PubMed ID: 3546147 [TBL] [Abstract][Full Text] [Related]
18. [Intracamera penetration of ofloxacin in man]. Bron A; Talon D; Delbosc B; Estavoyer JM; Kaya G; Royer J J Fr Ophtalmol; 1987; 10(6-7):443-6. PubMed ID: 3500972 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis. Cazzola M; Matera MG; Donnarumma G; Tufano MA; Sanduzzi A; Marchetti F; Blasi F Chest; 2005 Oct; 128(4):2093-8. PubMed ID: 16236860 [TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent. Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]